announcement

Bluebird bio Inc

company

$BLUE seriously, how can a company be so bad at execution?

.i hate this fuccccccing company 🖕🏼🖕🏼🖕🏼

Plenty of other companies are mentioned and while we can pick one or two sentences out of the lengthy form that might make you get excited i just do not believe theres anything there indicating a BO or even a partnership.

It’s agonizing as we have not heard a feedback or response from the company regarding it. 1.

$BLUE The overall Market and the delay (NO COMMUNICATION) from the company leads to a substantial decrease in stock value.

Seems like company management hates its own shareholders

$BLUE this company is so defenseless, they don&#39;t even delete the vulgar replies to their tweets.

hand

didnt know there were so many weak hands.

Cash on hand going DOWN daily with no progress toward commercialization.

They use many tactics to scare the money right out of your hands.

but the cash burn compared with cash on hand is concerning.

It means they are worried and with do whatever is necessary to scare weak hands.

loss

Losses creating more losses to recoup other losses lol

$BLUE   Well, lol, beginning with ZERO DOLLARS , this statement is not ROCKET  SCIENCE, lol, yet, yet , earnings will still show a LOSS against revenues !!!

The idea of selling this at a $3,000 loss after sitting on it since July is unacceptable.

Now I am  sitting just about at a loss hope there isn’t much more downside.

$BLUE the stop losses getting triggered today must be frustrating.

$PRVB reported losses and missed revenue target. BOOM.

move

Everything else moves and we just sit in the same spot.

$BLUE   Well well well…..up 300 on the DOW and this pos , is that, a turd.

This pos was $6.50 after they got their first drug approved , lol…Aug 2022..and you are still here at $6.50 !!!!

And so, you have it…a lousy ending to this pos

This pos burnt so many from $100, they changed mgmt and it still hasn’t fixed the problem.

Here to make money, this pos doesn’t deserve to be even listed.

Fantastic company with solid balance sheet and exclusivity contracts being announced left and right.

I can trade in and out with no fear of missing BO announcement.

$BLUE agreed, even without a b/o, too much bullish fundamental news and any announcement on further progress on pipeline or ramping up the current 2 approvals should provide fuel for that push through double digits

Today&#39;s announcement is good news for BLUE.

As soon as they announce the Republicans win the house the market will soar and BLUE will be flying to the top.

$BLUE Last minute announcement that they&#39;re presenting on the 8th can only be good.

In the process of the transfer  They will probably announce and I will miss out on half🙂 Bullish

$BLUE  
VERU 
∙ 11/9 Adcom 
∙ High Efficacy (COVID WHO 4/5 pts) 
∙ Excellent Safety traits 
∙ Positive Peer Review completed 
∙ NEJM published  
∙ SI = 25% 
∙ EUA for Sabizabulin = $$$$$$$$$$$$

news

but good news, I am sending Andrew a gift! https://bagofdicks.com/

The silence will break soon with really good news

$BLUE tuff market   But good news around the corner.

$BLUE The most positive news is it’s one day closer to the earnings release and one day closer to the BLA submission plus this is currently a rare day where this is beating out the XBI and LABU by not being down as much.

$BLUE very bullish here and ready for news any moment or day

I would expect some very good news and a turn around to come very soon. 🤞

This is trading like good news is coming! !

potential

Way to maximize the talent pool and help everyone reach their potential BLUE!!

Watching these for potentially more upside continuation next week.

Large potential population of users
6. good/honest management
7.

Sign up today and start receiving expert insights on potential market opportunities 
 
📈FREE trade-of-week via(Google Search) ⟶  𝐟𝐫𝐞𝐞𝐚𝐥𝐞𝐫𝐭.𝐩𝐰

though because there is just  so much potential for BLUE now.

entry

Good entry on friday..ill wait for a 10% profit..amd out, untul next leg.. 🤑🤑🤑

$BLUE almost $4, may be is s good entry point soon.

Attractive entry for the long term potential here.

$BLUE well if there was ever a good entry point it was there today in my opinion

We provide all ENTRIES and EXITS clearly!

We provide all of our ENTRIES and EXITS for the plays, give you the plan and guide you along those plans.

InflaRx N.V.

covid

Makes one wonder what frame of reference is being used to label this pandemic over: seems to me that the pandemic of hyperinflammation continues to rage, and getting worse.

$IFRX Sadly 2.3k deaths this past week were recorded in Japan attributable to covid, following last week’s previous record of 2.2k deaths, despite overwhelming prevention through antivirals, unlike China’s prevention approach.

$IFRX after 2 years of this pandemic it has now hit me too, yesterday I had severe flu-like symptoms and today severe coughing phlegm.

Great publicity for anti-C5a biotech (and kinda funny too since Staidson also  put out their standard “Announcement on Abnormal Fluctuations in Stock Trading”).

If you look at Veru&#39;s announcement from 24/10 for me they look much better.

The perfect dream scenario would be to get a Covid EUA and then a Mrk shocker for the onc world!

$IFRX C&#39;mon - EUA imminent 🚀 🚀 🚀 🚀 🚀 🚀 🚀 💪

$XBI Come to where the flavor is, come to $IFRX ❤️ EUA imminent 👌

May your heart be warmed by the sweet magic that Christmas always brings, and may all your dreams be fulfilled, EUA for example 🎄

$IFRX FANT‼️‼️ EUA approval any moment now.

$IFRX This is great that we have already much more attention, once EUA arrive the stock will explode to minimum 5$ 
 
🚀🚀🚀🚀🚀🚀🚀

$IFRX News this week 🤞🤞🤞😁😁😁

$IFRX good news   ed got the short shares covered 
 
https://iborrowdesk.com/report/IFRX

$IFRX FANNY 🚀🚀 
 
FAntastic 
News on 
New  
Year

Upside: further good news from China and approval.

Premarket stock gainers on news and/or vol.

application

$IFRX we should get year end report late march   if we have nothing from fda, ema or china we can only hope for cancer trial because pg is 2 years and an offering(s)  away       I’m a bull with alot of shares

$IFRX FDA approve now..vilo works and is safe!

Many options, FDA, NMPA and EMA. 🚀🚀🚀🤞🤞

I like Ifx-1’s chances of fda approval.

approval

PG treated with 2400mg/vilo is the strongest indication yet of vilo’s effectiveness =  approval.

An approval would give it backbone, and further approvals will give it explosive growth.

$IFRX Vilo approval during Green Week, the stuff of poetry.

$IFRX nice to see us finally moving   an extra 2.5 mil is nice should have our cash at least 93 mil with no debt   with ema approval we will tap those final  funds from german government and fda approval should hopefully send us into orbit

Approvals &amp; encouragements are lining up nicely with the pipeline.

$IFRX Monday is a good day for approvals - FANM 🤞🤞🤞🤞

Edesa Biotech Inc

A company to lose close to 25% in 3 days on no news shows Gary is absolutely USELESS.

$EDSA Whatever the news is (that somehow got leaked and is responsible for this going up more than 100% in a week) once it is properly announced I will GTFO and never come back to this Indian scammer Pars POS stock.

but watching APVO today is not very comforting for when we release news.

$EDSA These shitheads aren’t sharing the good news.

I simply want to see Edesa Biotech management try to put out any positive news release during this year and then realize that their news release once again had the opposite effect in moving the share price down another 41%+ during that day.

40-50% crushed on good news and then no rallies at all.

rate

Patients with rapidly improving ARDS still had a 55% mortality rate, much higher than earlier reported.

but embarrassingly, the FDA isn&#39;t impressed with an 84% death reduction rate? WTF?

3) QUESTIONABLE TRIAL GROUP - High placebo mortality rate and wide variance of dosed patients (L4 - L6) make it impossible to know what patient exactly should receive the  drug in Emergency Use, hence why they would like to see another trial.

Lowers the body temperature almost immediately, almost at an disturbing rate.

Short Borrow Fee rate has increased from approx 6% to 8% !!!!

Still don’t think it deserved an 8k when we can’t even get main asset trial approval prs for years.

but it scares the shite out of me that the FDA has not approved our trial in over a year.

but starting phase 3 sometime this year, eb05 in trials and asking for fda phase 3 approval in numerous USA sites, just announced a EB06 trial starting in Canada and eb07 coming soon this would have to be the most idiotic bio company in Canadian history.

$EDSA they have 2 products, both of which are not FDA approved.

It seems a wee bit like some kind of half broken pump which had been purchased from a  bargain basement or fire sale clearance kind of vendor or a PUMP which would be purchased from some gold caps toothed Tamil Sri Lankan, lol.

1) Phase 3 FDA approval is imminent as it makes no sense for them to acknowledge the need for this drug and not be more flexible with the trial protocol.

The only reason VERU did not get EUA approval was due to a weak safety profile.

And the pipeline chart on website is so misleading cuz our P3 protocol is even not yet approved by FDA

business-result

$EDSA 

EBO1 Stat Sig results

Reached Primary Endpoint 

Dropped 44%? WTF?

$EDSA disappointing management hasn’t come out defending the EB01 results.

$EDSA long time bulls like Mr. Bitcoins are leaving forever after these terrible EB01 allergic contact dermatitis results … it’s over sad to say … at least the company tried their best,

But, let me tell you why the Bulls have disappointed me - nobody seemed able to defend these top line results and the Bears for being stupid lucky.

$EDSA Results were not good and even more concerning was that the higher regarded 2% dose showed nothing.

There may be potential to improve the results further.

but they can pass on their illness to others and, as a result, you need to protect yourself from them.

The delay is merely serving long ago determined intents on the part of this fack named Par and his fellow Edesa Biotech accomplices; and we may be losing just shy of every single penny we place here with Edesa Biotech Inc as a result.

executive

Edessa is dead and her CEO is a swindler.

Wouldn’t it be great if the CEO could even spare 1 hour every quarter to write a shareholder letter…

The CEO adding provides me no solace anymore.

Small buys by the President and CFO, and yet the share price just keeps collapsing.

EUA any day… 
 
So glad I’m not short AND have my biggest position here than EVER  before.

What I love about this stock is the probability of EUA Filing and the fact WE DON&#39;T HAVE TO WAIT FOR FDA APPOVAL IF EU, THE STOCK WILL EXPLODE ON THE FILING ALONE!

but my god everything has aligned for some very very very good news

$EDSA Not a single negative news about this stock and yet the price is falling .

$EDSA friends 
 
Great news 
 
In 2027 we might reach a profit 
 
Hahahahahahahahahaha

but I like what the company is trying to do/develop and the good it would do if successful.

$EDSA multiple billion dollar company. 🤦‍♀️

but this company never ceases to disappoint.

$EDSA Pretty pretty pretty neat  that myself and 3 other retail I know own around 5% of this company.

But, I do think good things are coming the way of this company before June.

$EDSA I’m literally so feed up with this company and stock.

One thing you have to give props to this company is their management of cash.

volume

$EDSA -9% on 50k volume is an astonishing accomplishment.

Short volume Ratio for last EIGHT straight trading days is averaging about 60%+

🧐

$EDSA last night&#39;s close was a very good close with very good share volume

however what we can see, apart from all our assumptions about it, right or wrong, the volumes are high compared to the previous months, which means a lot of interest in the title

$EDSA Reasonable volume everyday since 12/20.

$EDSA good volume today 1.5 of average 
We are on the right path

then news..then some real volume..up up and away

$EDSA the fact that this rise has been steady and medium volume is a good thing.

BLUE

Bluebird bio Inc

-31.24%

$6.69 - $4.60

Mar, 16, 2023

Jan, 18, 2023

IFRX

InflaRx N.V.

-20.18%

$2.23 - $1.78

Dec, 21, 2022

Oct, 26, 2022

EDSA

Edesa Biotech Inc

-24.09%

$1.37 - $1.04

Mar, 15, 2023

BLUE

Bluebird bio Inc

-31.24%

$6.69 - $4.60

Mar, 16, 2023

Jan, 18, 2023

Jan, 13, 2023

Dec, 20, 2022

Nov, 9, 2022

Nov, 5, 2022

Oct, 26, 2022

IFRX

InflaRx N.V.

-20.18%

$2.23 - $1.78

Dec, 21, 2022

Oct, 26, 2022

EDSA

Edesa Biotech Inc

-24.09%

$1.37 - $1.04

Mar, 15, 2023